| Patient | TERT promoter mutation | BRAF V600E | ALK rearrangement | |||
---|---|---|---|---|---|---|---|
C228T | C250A | C250T | Overall | ||||
WDTC without distant metastasis | 192 | 0 | 0 | 0 | 0 | 142 (74Â %) | 0 |
 PTC, classic | 127 | 0 | 0 | 0 | 0 | 110 (87 %) | 0 |
 PTC, classic with TCF | 11 | 0 | 0 | 0 | 0 | 10 (91 %) | 0 |
 PTC, EFV | 9 | 0 | 0 | 0 | 0 | 1 (11 %) | 0 |
 PTC, IFV | 7 | 0 | 0 | 0 | 0 | 5 (71 %) | 0 |
 PTC, tall cell | 16 | 0 | 0 | 0 | 0 | 15 (94 %) | 0 |
 PTC, oncocytic | 1 | 0 | 0 | 0 | 0 | 1 (100 %) | 0 |
 PTC, Warthin-like | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
 FTC, minimally invasive | 20 | 0 | 0 | 0 | 0 | 0 | 0 |
WDTC with distant metastasis | 30 | 10 (33Â %) | 0 | 2 (7Â %) | 12 (40Â %) | 15 (50Â %) | 0 |
 PTC, classic | 14 | 3 (21 %) | 0 | 0 | 3 (21 %) | 7 (50 %) | 0 |
 PTC, classic with TCF | 4 | 2 (50 %) | 0 | 1 (25 %) | 3 (75 %) | 4 (100 %) | 0 |
 PTC, EFV | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
 PTC, macrofollicular | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
 PTC, tall cell | 5 | 4 (80 %) | 0 | 0 | 4 (80 %) | 3 (60 %) | 0 |
 PTC, columnar cell | 1 | 0 | 0 | 1 (100 %) | 1 (100 %) | 1 (100 %) | 0 |
 PTC, diffuse sclerosing | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
 FTC, minimally invasive | 2 | 1 (50 %) | 0 | 0 | 0 | 0 | 0 |
 FTC, widely invasive | 1 | 0 | 0 | 0 | 1(100 %) | 0 | 0 |
Poorly differentiated carcinoma | 7 | 1 (14Â %) | 1 (14Â %) | 0 | 2 (29Â %) | 1 (14Â %) | 0 |
Anaplastic carcinoma | 5 | 2 (40Â %) | 0 | 1 (20Â %) | 3 (60Â %) | 4 (80Â %) | 0 |
Medullary carcinoma | 9 | 0 | 0 | 0 | 0 | 0 | 0 |